Benjamin Fisher

23PUBLICATIONS
83CO-AUTHORS
AutoimmunityBehavioural epidemiologyNeurology and neuromuscular diseasesSocial epidemiologyCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (23)

|Jun 24, 2026
Emerging treatments for Sjögren's disease: promising drugs on the horizon.

|Jun 24, 2026
Impact of smoking status on Sjögren's disease diagnosis and phenotype: results from a cohort study with matched population controls.

|Jun 19, 2026
Clinical features and pathogenesis of Sjogrens disease related peripheral neuropathy and their relevance to clinical trials.

|Apr 17, 2026
The autoantigen TRIM21 assembles proinflammatory immune complexes after lytic cell death.

|Mar 04, 2026
Impact of socioeconomic deprivation on risk and disease activity of Sjögren's disease.

Aliaksandra Baranskaya, Matilde Bandeira, Abdullah Nadeem

|Mar 03, 2026
Pragmatic, open-label, multicentre, randomised controlled trial to guide initial therapy for immune checkpoint inhibitor-induced inflammatory arthritis comparing standard of care (prednisolone) to adalimumab without glucocorticoids: REACT trial protocol.

Benjamin A Fisher, Anna Rowe, Chris Hodson

Pageof 4

Frequent Collaborators

3 joint publications

Nurhan Sutcliffe

3 joint publications

Simon J Bowman

3 joint publications

Valentina Pucino

2 joint publications

Davide Lucchesi